Clinical Trial Update: GB-PRIME: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for the Control of External Devices [NA]

View source ↗

Summary

An early-feasibility study of a robotically implanted brain-computer interface (GB-PRIME) by Neuralink for controlling external devices. Recruitment is underway…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Brainstem Stroke
• Spinal Cord Injury

Snippet

Sponsor: Neuralink Corp | Conditions: Tetraplegia/Tetraparesis, Quadriplegia | NA | Status: RECRUITING